Exchange: OTC·Updated 10:09 AM EST

RGRX Regenerx Biopharmaceuticals

$0.0003
$0.00
(0.00%)
Today
Mkt Cap$449.00
Vol3.00

About RGRX

RegeneRx Biopharmaceuticals, Inc. engages in the development of a novel therapeutic peptide, Thymosin beta 4 for tissue and organ protection, repair, and regeneration. Its product pipeline includes RGN-259, RGN-352, and RGN-137. The company was founded by Allan L. Goldstein on May 13, 1982 and is headquartered in Glen Echo, MD.
44

Bearish Sentiment

How do you feel about RGRX?

Advertisement|Remove ads.